Skip to main content

Intraveneously injected unusual nanoparticles in the clinic

Project description

Nanoparticle-based, non-invasive chronic inflammation biomarkers

Treatment of unresolved chronic inflammation that leads to the development of many diseases, including cancer, cardiovascular diseases, autoimmune diseases, neurological diseases and rheumatoid arthritis, has to involve longitudinal image-based characterisation of the process. There is an unmet need for non-invasive diagnostic technology that can be used in conjunction with conventional bio-fluid and biopsy markers. This is particularly important in cases when treatment requires long-term preventative lifestyle changes. The EU-funded Unusual-IV project aims to develop clinical non-invasive, nanoparticle-based biomarkers of inflammation that can help in diagnostics, prediction of the outcome, and the assessment of the response to therapy or preventative strategy.

Host institution

CENYA IMAGING B.V.
Net EU contribution
€ 150 000,00
Address
Tweede Kostverlorenkade 11H
1052RK Amsterdam
Netherlands
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
No data
Region
West-Nederland Noord-Holland Groot-Amsterdam
 

Beneficiaries (1)

CENYA IMAGING B.V.
Netherlands
Net EU contribution
€ 150 000,00
SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Address
Tweede Kostverlorenkade 11H
1052RK Amsterdam
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
No data
Region
West-Nederland Noord-Holland Groot-Amsterdam